Onconetix, Inc. Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
Onconetix, Inc. (ONCO) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $3.53 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2024-12-10
- Onconetix, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-09-30 was $0.00.
- Onconetix, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-06-30 was $1.24M.
- Onconetix, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2024-03-31 was $2.29M.
- Onconetix, Inc. impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2023 was $14.69M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $1.24M derived: sum of 2 quarters · filed 2024-12-10 | $3.53M 10-Q · filed 2024-12-10 | |
| 2024-06-30 | $1.24M 10-Q · filed 2024-08-29 | $3.53M 10-Q · filed 2024-08-29 | ||
| 2024-03-31 | $2.29M 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | $14.69M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |